S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Zenas BioPharma, Inc.

ZBIO Healthcare
$26.4 +$0.29 (1.11%)
Market Cap: $1.42 B
Gurus Holding
1
Popularity Rank
#4084
% of Shares Held
0.05%
Net Activity (Q4 2025)
-$0

Guru Ownership Trend

Guru Analysis for Zenas BioPharma, Inc. (ZBIO)

Zenas BioPharma, Inc. (ZBIO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $649,017.6.

Top institutional holders include Cliff Asness.

Institutional sentiment is currently Neutral. Capital flow remained balanced this quarter with no significant net changes.

On the selling side, Cliff Asness reduced exposure by 0.3%.

Key Holders

Top 5 by Value

$545,765

Top 5 by Conviction

0.00%

Recent Activity Breakdown (Q4 2025)

+$0
Total Buy Value
New Buys 0
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
0

FAQs for Zenas BioPharma, Inc. (ZBIO)

Major holders include Cliff Asness ($545,765). According to the latest reported data, 1 tracked investment managers collectively hold approximately 24,584 shares.

No tracked managers reduced or fully exited their positions in ZBIO during the most recent reporting period.

No tracked managers opened new positions or increased their holdings in ZBIO during the most recent reporting period.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -0.3% 24,584 $545,765 Q3 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form